Cargando…
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
The high energy demands of the substantia nigra pars compacta dopaminergic (DASNc) neurons render these neurons vulnerable to degeneration. These energy demands are a function of their long and extensively arborized axons and very large number of transmitter release sites, and are further augmented...
Autor principal: | Mamelak, Mortimer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5990513/ https://www.ncbi.nlm.nih.gov/pubmed/29368093 http://dx.doi.org/10.1007/s40120-018-0091-2 |
Ejemplares similares
-
Prevention of Lipotoxicity in Pancreatic Islets with Gammahydroxybutyrate
por: Yung, Justin Hou Ming, et al.
Publicado: (2022) -
Parkinson's disease and dopaminergic neurons
Publicado: (2012) -
Cognitive Impairment Following Clinical or Recreational Use of Gammahydroxybutyric Acid (GHB): A Systematic Review
por: van Amsterdam, Jan, et al.
Publicado: (2022) -
Vulnerability of Mesostriatal Dopaminergic Neurons in Parkinson's Disease
por: González-Hernández, Tomás, et al.
Publicado: (2010) -
Roles of FGF20 in dopaminergic neurons and Parkinson's disease
por: Itoh, Nobuyuki, et al.
Publicado: (2013)